NZ202357A - Imparting anticoagulant coating to substrate - Google Patents
Imparting anticoagulant coating to substrateInfo
- Publication number
- NZ202357A NZ202357A NZ202357A NZ20235782A NZ202357A NZ 202357 A NZ202357 A NZ 202357A NZ 202357 A NZ202357 A NZ 202357A NZ 20235782 A NZ20235782 A NZ 20235782A NZ 202357 A NZ202357 A NZ 202357A
- Authority
- NZ
- New Zealand
- Prior art keywords
- parts
- range
- substrate
- coating
- silicone containing
- Prior art date
Links
- 238000000576 coating method Methods 0.000 title claims description 59
- 239000011248 coating agent Substances 0.000 title claims description 52
- 239000000758 substrate Substances 0.000 title claims description 33
- 239000003146 anticoagulant agent Substances 0.000 title claims description 8
- 229940127219 anticoagulant drug Drugs 0.000 title claims description 8
- 229960002897 heparin Drugs 0.000 claims description 46
- 229920000669 heparin Polymers 0.000 claims description 46
- 229920001296 polysiloxane Polymers 0.000 claims description 45
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 22
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 15
- 229910021641 deionized water Inorganic materials 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- -1 heparin compound Chemical class 0.000 claims description 8
- 230000002209 hydrophobic effect Effects 0.000 claims description 8
- 230000002429 anti-coagulating effect Effects 0.000 claims description 7
- 238000009534 blood test Methods 0.000 claims description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 3
- 150000001241 acetals Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229940109239 creatinine Drugs 0.000 claims description 2
- 229960001484 edetic acid Drugs 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229920001897 terpolymer Polymers 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- BEGBSFPALGFMJI-UHFFFAOYSA-N ethene;sodium Chemical group [Na].C=C BEGBSFPALGFMJI-UHFFFAOYSA-N 0.000 claims 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 238000007567 mass-production technique Methods 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 239000000243 solution Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 4
- MEUAVGJWGDPTLF-UHFFFAOYSA-N 4-(5-benzenesulfonylamino-1-methyl-1h-benzoimidazol-2-ylmethyl)-benzamidine Chemical compound N=1C2=CC(NS(=O)(=O)C=3C=CC=CC=3)=CC=C2N(C)C=1CC1=CC=C(C(N)=N)C=C1 MEUAVGJWGDPTLF-UHFFFAOYSA-N 0.000 description 1
- 241001214714 Niea Species 0.000 description 1
- VYTBPJNGNGMRFH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O VYTBPJNGNGMRFH-UHFFFAOYSA-N 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C17/00—Surface treatment of glass, not in the form of fibres or filaments, by coating
- C03C17/28—Surface treatment of glass, not in the form of fibres or filaments, by coating with organic material
- C03C17/30—Surface treatment of glass, not in the form of fibres or filaments, by coating with organic material with silicon-containing compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S215/00—Bottles and jars
- Y10S215/03—Medical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/92—Method or apparatus for preparing or treating prosthetic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Geochemistry & Mineralogy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/326,712 US4529614A (en) | 1981-12-02 | 1981-12-02 | One step anticoagulant coating |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ202357A true NZ202357A (en) | 1984-12-14 |
Family
ID=23273353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ202357A NZ202357A (en) | 1981-12-02 | 1982-11-01 | Imparting anticoagulant coating to substrate |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4529614A (enExample) |
| EP (1) | EP0080908B1 (enExample) |
| JP (1) | JPS5897367A (enExample) |
| AU (1) | AU553928B2 (enExample) |
| DE (1) | DE3265662D1 (enExample) |
| NZ (1) | NZ202357A (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3523969A1 (de) * | 1985-07-04 | 1987-01-08 | Boehringer Mannheim Gmbh | Gerinnungsneutrale, hydrophile glasfasern |
| US4851337A (en) * | 1986-01-08 | 1989-07-25 | Hygeia Sciences, Inc. | Extraction of test substances |
| US4698207A (en) * | 1986-07-14 | 1987-10-06 | Baxter Travenol Laboratories, Inc. | Integrated membrane oxygenator, heat exchanger and reservoir |
| US4808449A (en) * | 1986-08-25 | 1989-02-28 | Sherwood Medical Company | Method for applying a dried coating of biologicals to the interior of a container |
| US5061738A (en) * | 1988-04-18 | 1991-10-29 | Becton, Dickinson And Company | Blood compatible, lubricious article and composition and method therefor |
| US5013717A (en) * | 1988-04-18 | 1991-05-07 | Becton, Dickinson And Company | Blood compatible, lubricious article and composition and method therefor |
| US5254249A (en) * | 1989-04-25 | 1993-10-19 | Toray Industries, Inc. | Anti-thrombogenic blood treating system |
| AU629412B2 (en) * | 1989-11-30 | 1992-10-01 | Becton Dickinson & Company | Selective fungal medium |
| US5843089A (en) | 1990-12-28 | 1998-12-01 | Boston Scientific Corporation | Stent lining |
| JP2858045B2 (ja) * | 1991-05-31 | 1999-02-17 | バクスター インターナショナル インコーポレーテッド | 脱泡用途に関する抗凝血性コーチング |
| JPH06242106A (ja) * | 1993-02-01 | 1994-09-02 | Becton Dickinson & Co | 採血器具 |
| US20020055710A1 (en) * | 1998-04-30 | 2002-05-09 | Ronald J. Tuch | Medical device for delivering a therapeutic agent and method of preparation |
| US5824048A (en) * | 1993-04-26 | 1998-10-20 | Medtronic, Inc. | Method for delivering a therapeutic substance to a body lumen |
| US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
| US5593639A (en) * | 1994-05-26 | 1997-01-14 | Japan Synthetic Rubber Co., Ltd. | Blood-sampling vessel |
| EP0698398A1 (en) * | 1994-08-23 | 1996-02-28 | Becton, Dickinson and Company | Blood collection device |
| US5624617A (en) * | 1994-12-30 | 1997-04-29 | Medtronic, Inc. | Method of manufacture for catheter lumen lubricity |
| US5820917A (en) * | 1995-06-07 | 1998-10-13 | Medtronic, Inc. | Blood-contacting medical device and method |
| US6238578B1 (en) * | 1996-12-09 | 2001-05-29 | Sherwood Services Ag | Method for dispensing separator gel in a blood collection tube |
| EP0900092A1 (en) * | 1996-05-03 | 1999-03-10 | Uros Corporation | Pentosanpolysulfate coating for medical devices |
| US5906744A (en) * | 1997-04-30 | 1999-05-25 | Becton Dickinson And Company | Tube for preparing a plasma specimen for diagnostic assays and method of making thereof |
| US6224830B1 (en) | 1998-01-30 | 2001-05-01 | The Governors Of The University Of Alberta | Absorbance cell for microfluid devices |
| CA2301838A1 (en) * | 1998-03-19 | 1999-09-23 | Sims Portex Inc. | Anticoagulant internally coated needle |
| DE19836559A1 (de) | 1998-08-12 | 2000-03-23 | Antigen Gmbh | Gefäß zur Entnahme von Blut |
| US6248127B1 (en) | 1998-08-21 | 2001-06-19 | Medtronic Ave, Inc. | Thromboresistant coated medical device |
| US6423348B1 (en) | 1998-12-15 | 2002-07-23 | James C. Mickus | Anticoagulant compositions |
| US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
| US6730349B2 (en) * | 1999-04-19 | 2004-05-04 | Scimed Life Systems, Inc. | Mechanical and acoustical suspension coating of medical implants |
| US6506408B1 (en) * | 2000-07-13 | 2003-01-14 | Scimed Life Systems, Inc. | Implantable or insertable therapeutic agent delivery device |
| US6630460B2 (en) | 2001-02-09 | 2003-10-07 | Medtronic, Inc. | Heparin compositions and methods of making and using the same |
| GB0117879D0 (en) * | 2001-07-21 | 2001-09-12 | Common Services Agency | Storage of liquid compositions |
| US6908622B2 (en) | 2001-09-24 | 2005-06-21 | Boston Scientific Scimed, Inc. | Optimized dosing for drug coated stents |
| WO2003041759A1 (en) * | 2001-11-13 | 2003-05-22 | Becton, Dickinson And Company | Spray dry process for applying anticoagulant on a syringe barrel |
| US20030165614A1 (en) * | 2002-03-01 | 2003-09-04 | Henrik Hansen | Coating a medical implant using a pan coater |
| US20040043505A1 (en) * | 2002-05-07 | 2004-03-04 | Matthew Walenciak | Collection assembly |
| AU2007300585A1 (en) * | 2006-09-21 | 2008-04-03 | Kyphon Sarl | Diammonium phosphate and other ammonium salts and their use in preventing clotting |
| GB0701821D0 (en) * | 2007-02-01 | 2007-03-14 | Pentapharm Ag | Diagnostic composition and its use in the determination of coagulation characteristics of a test liquid |
| WO2016073668A1 (en) * | 2014-11-06 | 2016-05-12 | The Regents Of The University Of Colorado | Identification of novel disease states using viscoelastic analysis in the presence of a thrombolytic agent |
| WO2016200765A1 (en) | 2015-06-08 | 2016-12-15 | The Regents Of The University Of Colorado, A Body Corporate | Time independent viscoelastic analysis parameter for prediction of patient outcome |
| US11169142B2 (en) | 2016-05-11 | 2021-11-09 | The Regents Of The University Of Colorado, A Body Corporate | Viscoelastic analysis in patients with disease associated with cardiovascular system |
| RU193728U1 (ru) * | 2019-04-17 | 2019-11-12 | Андрей Александрович Суворов | Двухсекционная пробирка с пленочным покрытием с пробозаборником и крышкой для укупоривания пробирки |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1159659A (en) * | 1966-06-23 | 1969-07-30 | Dow Corning | A Device for Use in Contact with Blood |
| CH496482A (fr) * | 1969-08-07 | 1970-09-30 | Lugon Georges | Procédé pour recouvrir la paroi interne d'un récipient d'une couche de fines particules séparées d'au moins un produit chimique |
| FR2114230A5 (enExample) * | 1970-11-20 | 1972-06-30 | Silicones Ste Indle | |
| FR2142277A5 (en) * | 1971-06-18 | 1973-01-26 | Gen Electric | Antithrombogenic surfaces |
| JPS5250399A (en) * | 1975-10-21 | 1977-04-22 | Agency Of Ind Science & Technol | Process for preparing anticoagulating organosilicon polymers |
| US4112925A (en) * | 1976-04-22 | 1978-09-12 | Corning Glass Works | Blood sample container having an anticoagulant coating of polyvinyl pyrrolidone and a salt of ethylene diamine tetracetate |
| JPS57103647A (en) * | 1980-12-20 | 1982-06-28 | Yoshiatsu Miura | Antithrombus material |
-
1981
- 1981-12-02 US US06/326,712 patent/US4529614A/en not_active Expired - Lifetime
-
1982
- 1982-10-15 AU AU89405/82A patent/AU553928B2/en not_active Ceased
- 1982-11-01 NZ NZ202357A patent/NZ202357A/en unknown
- 1982-11-15 JP JP57200249A patent/JPS5897367A/ja active Granted
- 1982-12-02 DE DE8282306421T patent/DE3265662D1/de not_active Expired
- 1982-12-02 EP EP82306421A patent/EP0080908B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU553928B2 (en) | 1986-07-31 |
| JPS5897367A (ja) | 1983-06-09 |
| EP0080908A1 (en) | 1983-06-08 |
| DE3265662D1 (en) | 1985-09-26 |
| EP0080908B1 (en) | 1985-08-21 |
| JPH0323178B2 (enExample) | 1991-03-28 |
| AU8940582A (en) | 1983-06-09 |
| US4529614A (en) | 1985-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4529614A (en) | One step anticoagulant coating | |
| Chinn et al. | Baboon fibrinogen adsorption and platelet adhesion to polymeric materials | |
| JP4689772B2 (ja) | 低結合性表面の作成方法 | |
| Nathan et al. | Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils. | |
| Takada et al. | Fluid shear stress increases the expression of thrombomodulin by cultured human endothelial cells | |
| Weyrich et al. | Activated platelets signal chemokine synthesis by human monocytes. | |
| Hoover et al. | The adhesive interaction between polymorphonuclear leukocytes and endothelial cells in vitro | |
| Videm et al. | Biocompatibility of extracorporeal circulation: in vitro comparison of heparin-coated and uncoated oxygenator circuits | |
| AU747910B2 (en) | New reagents and a method for the lysis of erythrocytes | |
| US5593824A (en) | Biological reagent spheres | |
| Dwyer | Leishmania donovani: surface membrane carbohydrates of promastigotes | |
| Vacquier et al. | The fucose sulfate polymer of egg jelly binds to sperm REJ and is the inducer of the sea urchin sperm acrosome reaction | |
| Di Virgilio et al. | Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. | |
| Springer et al. | Anti-N reagents in elucidation of the genetical basis of human blood-group MN specificities | |
| US20080026475A1 (en) | Method of Lysis of Erythrocytes | |
| US4711820A (en) | Method of siliconization of surfaces with lower alkyl silanes | |
| US7399471B2 (en) | Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use | |
| Tetaud et al. | Characterization of glucose transport and cloning of a hexose transporter gene in Trypanosoma cruzi. | |
| Adams et al. | Kinetics of platelet adhesion and thrombus growth | |
| Huang et al. | The α (1, 3)-fucosyltransferase Fuc-TIV, but not Fuc-TVII, generates sialyl Lewis X-like epitopes preferentially on glycolipids | |
| EP0984279A2 (en) | Evacuated blood collection tube for rapid blood coagulation | |
| JP3984407B2 (ja) | ガラス製品 | |
| Höpfner et al. | Selectin-blocking semisynthetic sulfated polysaccharides as promising anti-inflammatory agents | |
| McFarland et al. | Albumin-binding surfaces: in vitro activity | |
| Haque et al. | Complement-mediated leukocyte adherence to infective larvae of Dipetalonema viteae (Filarioidea): requirement for eosinophils or eosinophil products in effecting macrophage adherence. |